Literature DB >> 2302086

Leuko-araiosis on magnetic resonance imaging and speed of mental processing.

C Junqué1, J Pujol, P Vendrell, O Bruna, M Jódar, J C Ribas, J Viñas, A Capdevila, J L Marti-Vilalta.   

Abstract

The clinical significance of white matter abnormalities seen in brain imaging studies, termed leuko-araiosis (LA), still remains uncertain. Leuko-araiosis has been associated with a global decline in cognitive performance, although little is known about the cognitive functions that LA may account for. We present the correlates between LA severity on magnetic resonance imaging and mental deterioration in a selected sample of 41 elderly patients with vascular risk factors. We found that LA was related to performance on tasks measuring the speed of information processing and, in particular, on those that involve complex processes. This impairment can be important in producing reduction in daily living activities as it is in the support to the relationship found with some commonly used behavioral rating scales. Leuko-araiosis is also related to the presence of some primitive reflexes, suggesting that their disinhibition may be due to diffuse corticofugal fibers damage.

Entities:  

Mesh:

Year:  1990        PMID: 2302086     DOI: 10.1001/archneur.1990.00530020047013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  43 in total

1.  Periventricular white matter changes and oropharyngeal swallowing in normal individuals.

Authors:  R Levine; J A Robbins; A Maser
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438

Review 2.  Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review.

Authors:  John L Beyer; Robert Young; Maragatha Kuchibhatla; K Ranga R Krishnan
Journal:  Int Rev Psychiatry       Date:  2009

3.  White matter hyperintensities predict functional decline in voiding, mobility, and cognition in older adults.

Authors:  Dorothy B Wakefield; Nicola Moscufo; Charles R Guttmann; George A Kuchel; Richard F Kaplan; Godfrey Pearlson; Leslie Wolfson
Journal:  J Am Geriatr Soc       Date:  2010-01-26       Impact factor: 5.562

Review 4.  Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis).

Authors:  Zoltán Szolnoki
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

Review 5.  Magnetic resonance in patients with affective illness.

Authors:  W M McDonald; K R Krishnan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

6.  Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population.

Authors:  D M J van den Heuvel; V H ten Dam; A J M de Craen; F Admiraal-Behloul; H Olofsen; E L E M Bollen; J Jolles; H M Murray; G J Blauw; R G J Westendorp; M A van Buchem
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 7.  Neuropsychological functioning associated with high-altitude exposure.

Authors:  Javier Virués-Ortega; Gualberto Buela-Casal; Eduardo Garrido; Bernardino Alcázar
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

8.  Effect of white matter disease on functional connections in the aging brain.

Authors:  A F Leuchter; J J Dunkin; R B Lufkin; Y Anzai; I A Cook; T F Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

9.  White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.

Authors:  H Jokinen; H Kalska; R Mäntylä; R Ylikoski; M Hietanen; T Pohjasvaara; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

10.  INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY).

Authors:  William B White; Ravi Marfatia; Julia Schmidt; Dorothy B Wakefield; Richard F Kaplan; Richard W Bohannon; Charles B Hall; Charles R Guttmann; Nicola Moscufo; Douglas Fellows; Leslie Wolfson
Journal:  Am Heart J       Date:  2013-01-05       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.